ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 164 filers reported holding ADMA BIOLOGICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $150,604 | -2.3% | 42,068 | +0.7% | 0.00% | – |
| Q2 2023 | $154,161 | +16.6% | 41,778 | +4.6% | 0.00% | – |
| Q1 2023 | $132,258 | -15.2% | 39,957 | -0.6% | 0.00% | -100.0% |
| Q4 2022 | $155,929 | +73.3% | 40,188 | +8.6% | 0.00% | – |
| Q3 2022 | $90,000 | +26.8% | 37,004 | +2.3% | 0.00% | – |
| Q2 2022 | $71,000 | +91.9% | 36,170 | +78.5% | 0.00% | – |
| Q1 2022 | $37,000 | -5.1% | 20,265 | -26.5% | 0.00% | – |
| Q4 2021 | $39,000 | +25.8% | 27,576 | +56.6% | 0.00% | – |
| Q1 2021 | $31,000 | +10.7% | 17,612 | +20.6% | 0.00% | – |
| Q4 2020 | $28,000 | -45.1% | 14,603 | -31.4% | 0.00% | – |
| Q3 2020 | $51,000 | -20.3% | 21,292 | -3.1% | 0.00% | – |
| Q2 2020 | $64,000 | +82.9% | 21,978 | +82.0% | 0.00% | – |
| Q1 2020 | $35,000 | -55.7% | 12,073 | -38.6% | 0.00% | – |
| Q4 2019 | $79,000 | – | 19,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 9,104,275 | $32,593,305 | 10.83% |
| Altium Capital Management LP | 2,723,011 | $9,748,379 | 5.08% |
| Velan Capital Investment Management LP | 1,736,100 | $6,215,238 | 5.01% |
| AWM Investment Company, Inc. | 5,999,872 | $21,479,542 | 3.17% |
| Mesirow Financial Investment Management, Inc. | 72,677 | $260,184 | 1.13% |
| Caligan Partners LP | 597,513 | $2,139,097 | 0.98% |
| Perceptive Advisors | 6,984,319 | $25,003,862 | 0.83% |
| OBERWEIS ASSET MANAGEMENT INC/ | 2,078,400 | $7,440,672 | 0.79% |
| TANG CAPITAL MANAGEMENT LLC | 1,360,000 | $4,868,800 | 0.69% |
| EAM Investors, LLC | 967,146 | $3,462,383 | 0.67% |